Cannabinoid Medicine Specialist
Nurturing Nature Group Consultants are specialists within the medicinal use cannabinoid arena. Our mission is to translate medical data in order to present credible, reliable findings, which facilitate pharmaceutical and public health benefits.
A bioethical perspective is essential in representing Nurturing Nature Group Consultants guiding conscience regarding patient access to Cannabis for medicinal purposes. We maintain independent and scrupulously neutral scientific and political credibility as our most essential means to advance our client’s interests.
Medical Marijuana Science; Not Opinion
A thoughtfully progressive bioethical position is essential to our company’s mission.
We bring a generational wisdom that can connect with all people; plus an understanding of marketing differences with respect to a given culture’s acceptance or rejection of “medical” marijuana.
In 2019, we’re prepared to speak critically about Cannabis’ prohibition, but will not comment on recreational cannabinoid (“adult”) use until there is a better understanding of its public health benefits and risks as currently used.
Nurturing Nature offers evidence-based scientific services to advance endocannabinoid research and its clinical application within the practice of integrative medicine. We bring decades of strategic planning and risk management expertise to individuals, organizations, and businesses seeking tomorrow’s agriculturally sustainable methods today.
We emphasize best practice parameters for physician education, human clinical trial translational research, sustainable growth horticulture, and pharmaceutical grade processing. Responsible dispensing based on clinically therapeutic evidence-based data analyses is essential for optimal patient outcome. Patient education itself advances quality assurance measures for medical marijuana patients in need of safe and efficient compassionate care.
Explore our extensive information and research to learn the science behind medicinal marijuana.
– Professor Raphael Mechoulam
Hebrew University – Jerusalem, Israel
2017 – “As a Board-Certified physician anesthesiologist, you can bring the benefits from a long professional career’s work to cannabinoid’s therapeutic use in healthcare.
Your clinical backgrounds offer unique understandings of endocannabinoid medicine’s potential future that should be of significant value to this evolving new science.”
2019 – “Your outstanding review has addressed many important aspects very well indeed. I do hope that it reaches the hands of many readers, clinicians in particular! Congratulations. -R”
2017 & 2019 – Raphael Mechoulam, PhD. – The Father of Cannabinoid Medicine